Dr. Troy H. Guthrie Jr., MD

Dr. Guthrie practices at UF Health Rehabilitation Hospital - North in Jacksonville, Florida, part of UF Health.

Dr. Guthrie's NPI, 1073500328, was assigned on October 3, 2005. Dr. Guthrie graduated from Medical College of Georgia in 1971. Dr. Guthrie holds Florida license ME66255.

Dr. Guthrie's primary practice is UF Health Rehabilitation Hospital - North, at 15255 Max Leggett Pkwy, 2nd and 3rd Floors, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 456-8001.

Dr. Guthrie's primary practice is UF Health Rehabilitation Hospital - North in Jacksonville, Florida, part of UF Health. Dr. Guthrie is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is GenesisCare. Dmand AI also links Dr. Guthrie to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guthrie practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Guthrie's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Guthrie is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Guthrie's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Guthrie treats.

CMS data shows 887 Medicare services from Dr. Guthrie across 8 procedure codes in 2024, for 203 Medicare patients. Medicare paid $74,507 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 203 Medicare patients who saw Dr. Guthrie in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guthrie's median patient age at 69, with 50% women.

In 2024, Dr. Guthrie wrote 1,360 Medicare Part D claims for 176 patients. 73% of them were for generic drugs. CMS names the drug for 1,135 of them, across 36 drugs with 11 or more claims each, at $3,405,693 in total drug cost. In 2023, CMS named 1,158 claims across 37 drugs.

Dr. Guthrie accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Guthrie, published from 2009 to 2019. 2016 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Doxorubicin. Dr. Guthrie has published most often in Am J Hematol. Dr. Guthrie's most frequent co-authors are Dat Cao Pham, MD, Katherine Hanna Tkaczuk, MD and Foluso Olabisi Ademuyiwa, MD.

Dmand AI links Dr. Guthrie to 14 clinical trials, 5 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Bronchogenic and Carcinoma, Intraductal, Noninfiltrating. National Cancer Institute (NCI) sponsors the most, 5.

CMS Open Payments shows 130 general payments to Dr. Guthrie from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Bristol-Myers Squibb Company paid the most, $20,496.

Dmand AI lists 2 awards for Dr. Guthrie, most recently Regional Top Doctor in 2014.

Dr. Guthrie graduated from Medical College of Georgia in 1971. Dr. Guthrie is a member of ASCO.

Dr. Guthrie is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.